Agile Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced that Al Altomari, Chairman and Chief
Executive Officer, will participate in a virtual fireside chat at
the Piper Sandler 32nd Annual Healthcare Conference, being held
December 1-3, 2020.
The pre-recorded fireside chat is accessible
through the Investors section of the Agile Therapeutics website
The recording will be available at 10:00am ET today through
Thursday, December 3, 2020.
About Agile Therapeutics,
Inc.Agile Therapeutics is a women's healthcare
company dedicated to fulfilling the unmet health needs of today’s
women. Our product candidates are designed to provide women
with contraceptive options that offer freedom from taking a daily
pill, without committing to a longer-acting method. Our
initial product, Twirla®, (levonorgestrel and ethinyl estradiol)
transdermal system is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The
Company may occasionally disseminate material, nonpublic
information on the Company’s website.
Follow Agile on LinkedIn and
Contact: Matt RileyHead of Investor
Relations & Corporate